156 related articles for article (PubMed ID: 30616923)
1. SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?
Gordiienko I; Shlapatska L; Kovalevska L; Sidorenko SP
Clin Immunol; 2019 Jul; 204():14-22. PubMed ID: 30616923
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.
Romanets-Korbut O; Najakshin AM; Yurchenko M; Malysheva TA; Kovalevska L; Shlapatska LM; Zozulya YA; Taranin AV; Horvat B; Sidorenko SP
PLoS One; 2015; 10(2):e0118302. PubMed ID: 25710480
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
[TBL] [Abstract][Full Text] [Related]
5. CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.
Yurchenko MY; Kovalevska LM; Shlapatska LM; Berdova GG; Clark EA; Sidorenko SP
Immunol Cell Biol; 2010 Jul; 88(5):565-74. PubMed ID: 20231852
[TBL] [Abstract][Full Text] [Related]
6. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
[TBL] [Abstract][Full Text] [Related]
7. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
Gordiienko I; Shlapatska L; Kholodniuk VM; Kovalevska L; Ivanivskaya TS; Sidorenko SP
Exp Oncol; 2017 Dec; 39(4):291-298. PubMed ID: 29284783
[TBL] [Abstract][Full Text] [Related]
8. CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells.
Wang N; Morra M; Wu C; Gullo C; Howie D; Coyle T; Engel P; Terhorst C
Immunogenetics; 2001 Jul; 53(5):382-94. PubMed ID: 11486275
[TBL] [Abstract][Full Text] [Related]
9. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
10. CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells.
Shcherbina V; Gordiienko I; Shlapatska L; Gluzman D; Sidorenko S
Neoplasma; 2021 Jul; 68(4):760-769. PubMed ID: 33904315
[TBL] [Abstract][Full Text] [Related]
11. Analysis of expression and function of the co-stimulatory receptor SLAMF1 in immune cells from patients with systemic lupus erythematosus (SLE).
Liñán-Rico L; Hernández-Castro B; Doniz-Padilla L; Portillo-Salazar H; Baranda L; Cruz-Muñoz ME; González-Amaro R
Lupus; 2015 Oct; 24(11):1184-90. PubMed ID: 25920347
[TBL] [Abstract][Full Text] [Related]
12. CD150-mediated Akt signalling pathway in normal and malignant B cells.
Yurchenko M; Shlapatska LM; Romanets OL; Ganshevskiy D; Kashuba E; Zamoshnikova A; Ushenin YV; Snopok BA; Sidorenko SP
Exp Oncol; 2011 Mar; 33(1):9-18. PubMed ID: 21423089
[TBL] [Abstract][Full Text] [Related]
13. The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein.
Lin LT; Richardson CD
Viruses; 2016 Sep; 8(9):. PubMed ID: 27657109
[TBL] [Abstract][Full Text] [Related]
14. Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells.
De Salort J; Sintes J; Llinàs L; Matesanz-Isabel J; Engel P
Immunol Lett; 2011 Jan; 134(2):129-36. PubMed ID: 20933013
[TBL] [Abstract][Full Text] [Related]
15. Di-(2-ethylhexyl)-phthalate interferes with T-follicular helper cell differentiation and cytokine secretion through signaling lymphocytic activation molecule family member-1.
Han Y; Wang X; Pang X; Hu M; Lu Y; Qu J; Chen G
J Immunotoxicol; 2019 Dec; 16(1):155-163. PubMed ID: 31403359
[TBL] [Abstract][Full Text] [Related]
16. SLAMF1/CD150 expression and topology in prostate and breast cancer cell lines.
Gordiienko IM; Lykhova OO; Shcherbina VM; Shlapatska LM
Exp Oncol; 2021 Dec; 43(4):312-316. PubMed ID: 34967540
[TBL] [Abstract][Full Text] [Related]
17. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
18. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP.
Mehrle S; Schmidt J; Büchler MW; Watzl C; Märten A
Mol Immunol; 2008 Feb; 45(3):796-804. PubMed ID: 17692919
[TBL] [Abstract][Full Text] [Related]
20. SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.
Gordiienko I; Shcherbina V; Shlapatska L
Exp Oncol; 2024 Feb; 45(4):457-462. PubMed ID: 38328844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
